SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-052978
Filing Date
2013-09-30
Accepted
2013-09-30 11:00:24
Documents
8
Period of Report
2013-09-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v356113_8-k.htm 8-K 34047
2 EXHIBIT 10.1 v356113_ex10-1.htm EX-10.1 83992
3 EXHIBIT 10.2 v356113_ex10-2.htm EX-10.2 34091
4 EXHIBIT 10.3 v356113_ex10-3.htm EX-10.3 54549
5 EXHIBIT 10.4 v356113_ex10-4.htm EX-10.4 54282
6 EXHIBIT 10.5 v356113_ex10-5.htm EX-10.5 51041
7 EXHIBIT 99.1 v356113_ex99-1.htm EX-99.1 9737
8 GRAPHIC image_001.jpg GRAPHIC 6662
  Complete submission text file 0001144204-13-052978.txt   332234
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30975 | Film No.: 131121899
SIC: 3826 Laboratory Analytical Instruments